Articles about Life Sciences – Page 3 of 4

NanoString expands office and lab space

NanoString, a 12-year-old Seattle company whose tools help genetic researchers better analyze genes and molecules, is expanding its footprint in… Read More

Drug maker Novo Nordisk confirms new obesity R&D center in Seattle

Danish drug maker Novo Nordisk announced plans today to open a new obesity research unit in Seattle, a move that… Read More

Cancer research startup VentiRx lands $50M

Seattle’s biotech industry has been on an up-and-down roller coaster ride over the past 12 months, with layoffs and R&D… Read More

Big news for biotech: Novo Nordisk considering Seattle for new obesity R&D center

Seattle has been struck with some tough setbacks in the biotech community in the past few months, including the recent… Read More

Shares of Alder BioPharmaceuticals sink after Bristol-Myers Squibb deal falls apart

Shares of Alder BioPharmaceuticals continue to fall after the company received notice from partner Bristol-Myers Squibb Company after the giant drug company… Read More

NanoString chief medical officer J. Wayne Cowens passes away at the age of 67

Dr. J. Wayne Cowens, the chief medical officer at Seattle-based NanoString Technologies, has died at the age of 67. “We… Read More

Sticking close to innovation roots, Arch Venture Partners raises oversubscribed $400M fund

Arch Venture Partners has operated longer than most venture capital firms by sticking close to its knitting. And now the… Read More

The top 10 biggest financing deals in the Pacific NW

Juno Therapeutics stunned the startup community earlier this week when it announced $134 million in venture funding, bringing total financing… Read More

Cancer research company Immune Design sets IPO range at $12 to $14 per share

Seattle biotechnology company Immune Design, which is working on novel technologies that activate the body’s immune system to fight cancer,… Read More

Cancer research startup Immune Design files for $60 million IPO

Immune Design Corp., a Seattle biotechnology company developing technologies to activate the body’s immune system to fight cancer, has filed… Read More

Tacoma biotech Revalesio raising $40M to develop cures for inflammatory diseases

Tacoma may not be the first place you think of when biotechnology comes to mind, but one company from the… Read More

Seattle blood test startup Indi raises $47.25 million

Seattle’s life sciences industry is getting another boost. Integrated Diagnostics, a Seattle company developing blood-based proteomic tests, has raised $30.25… Read More

More funding for cancer research in Seattle: Adaptive Biotechnologies raises $105M

Researchers from Seattle who are finding ways to eliminate cancer are bringing in some serious funding today. On the same… Read More

Alder BioPharma files for $115M IPO, looks to use cash for migraine and arthritis treatments

Seattle has seen a strong string of IPOs in the past few years — from Zillow to Tableau to Zulily.… Read More

Biotech investor Thong Le named CEO of Accelerator Corp.

Thong Le has taken the helm of Accelerator Corp., the Seattle-based investment firm that bankrolls emerging startups in the biotechnology… Read More

NanoString files for $55M stock offering, expects 37% revenue growth for 2013

NanoString Technologies, a provider of life science tools for research and molecular diagnostic products, has filed to raise $55 million… Read More

Tumor paint startup Blaze Bioscience raises $9M to help surgeons pinpoint cancer cells

Blaze Bioscience has raised $9 million in fresh funding from individual investors, money that the Seattle spinoff of the Fred… Read More

Money-losing Dendreon to cut 150 employees in bid to become ‘nimble’ biotech company

Once a rising star in Seattle’s biotechnology community, Dendreon Corp. announced Tuesday that it is reducing its staff by 15… Read More

Cancer research startup Immune Design pulls in $32.5 million, plans to raise more

Immune Design has reeled in $32.5 million in venture capital financing, with plans to raise up to $16.5 million more… Read More

Tech Moves: Skype exec departs Microsoft; Frazier Healthcare taps new VC; etc.

—Skype executive Mark Gillett is leaving Microsoft, taking a new position at private equity firm Silver Lake, reports Kara Swisher… Read More

Ex-Dendreon CEO starts healthcare investment fund Alpine BioVentures

Former Dendreon CEO Mitch Gold has partnered with biotechnology stock researcher David Miller to create a new Seattle-based investment firm… Read More

NanoString sets IPO range of $13-$15, plans to trade on Nasdaq under ticker NSTG

Seattle’s NanoString Technologies today set the terms for its upcoming initial public offering, with plans to sell shares in the… Read More

Mobisante raises $4.2M for smartphone-based ultrasound imaging system

Mobisante, the Redmond-based company that makes ultrasound technology viewable on a smartphone or tablet, just pulled in $4.2 million in fresh… Read More

Medical device maker Ekos acquired in $180M deal

Ekos, a Bothell medical device maker whose catheter-based ultrasound devices are used to break up blood clots in legs, has… Read More

Bruce Montgomery biotech startup Cardeas Pharma raises $34 million

It has been a good week for the Seattle life sciences community. On Monday, Seattle genomics tool maker NanoString Technologies… Read More

Frazier buys pharmaceutical packaging company AndersonBrecon

Seattle venture capital firm Frazier Healthcare has joined with Philadelphia-based Packaging Coordinators to purchase AndersonBrecon, a leading contract pharmaceutical packing company. The… Read More

BeatBio gets $2.5M for new ‘super fuel’ that boosts pumping power of heart muscles

BeatBio, a Seattle life sciences startup led by former Vulcan Capital managing director Michael Kranda and former VieVax CTO Gregory… Read More

Microsoft’s Craig Mundie joins board of Institute for Systems Biology

We’re getting a better idea of how longtime Microsoft executive Craig Mundie is going to spend some of his time… Read More

Theraclone raises $14M to ID rare human antibodies that could be used to fight disease

Seattle biotechnology company Theraclone Sciences has raised an additional $8 million in equity financing and $6 million in debt, bringing… Read More

Blaze Bioscience raises $8.5M to help surgeons pinpoint cancer cells with ‘tumor paint’

Seattle biotechnology startup Blaze Bioscience has raised $8.5 million to continue developing technologies that are designed to help surgeons more… Read More